Yu Miyama

7PUBLICATIONS
12CO-AUTHORS
Medical mycologyHeritage, archive and museum studies not elsewhere classifiedMolecular targetsPredictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 29, 2025
Multi-institutional study of mesonephric-like adenocarcinoma: its clinicopathological characteristics and histogenetic association with ectopic endometrium.

Yu Miyama, Kousuke Uranishi, Masataka Hirasaki

|Mar 15, 2024
Carcinoma showing thymus-like elements (CASTLE) with amyloid deposition in the parotid gland.

Mei Hamada, Yu Miyama, Satoko Matsumura

|Jan 06, 2023
Complete response to pembrolizumab in a patient with recurrent and metastatic urothelial bladder carcinoma reflecting coexisting sarcomatoid subtype and glandular differentiation: a case report.

Yu Miyama, Kent Kanao, Kousuke Uranishi

|Jun 14, 2022
Lower neutrophil-to-lymphocyte ratio and positive programmed cell death ligand-1 expression are favorable prognostic markers in patients treated with pembrolizumab for urothelial carcinoma.

Yu Miyama, Go Kaneko, Koshiro Nishimoto

|Dec 21, 2020
Hepatoid adenocarcinoma of the lung mimicking metastatic hepatocellular carcinoma.

Yu Miyama, Takeshi Fujii, Kyoko Murase

|Oct 28, 2020
An autopsy case of prostatic rhabdomyosarcoma with DICER1 hotspot mutation.

Yu Miyama, Naohiro Makise, Jimpei Miyakawa

Pageof 2

Frequent Collaborators

2 joint publications

Masanori Yasuda

1 joint publications

Naohiro Makise

1 joint publications

Takeshi Fujii

1 joint publications

Kyoko Murase